期刊文献+

间皮素mRNA及蛋白在卵巢癌中的表达及分析 被引量:3

Expression of mesothelin mRNA and protein in ovarian carcinomas
原文传递
导出
摘要 目的研究间皮素(MESO)在卵巢癌中的表达及意义。方法用逆转录聚合酶链反应(RT—PCR)技术和免疫组化方法分别检测卵巢肿瘤和正常卵巢组织中MESO mRNA及其蛋白水平。结果MESO mRNA和蛋白在上皮性卵巢癌(1.4005±0.4646,2.7857±2.2712)和交界性卵巢肿瘤(1.0650±0.3100,2.9167±2.391)中的表达水平高于良性卵巢肿瘤(0.6463±0.2419,1.2500±1.6125)和正常卵巢组织(0.6439±0.2729,0.9167±1.2401),差异有统计学意义(P〈0.05);MESOmRNA和蛋白在浆液性卵巢癌(1.5255±0.4151,3.3036±2.6141)和子宫内膜样癌(1.5250±0.5419,3.0000±2.3094)中的表达水平高于黏液样癌(1.0675±0.3149,1.0556±1.9242),差异有统计学意义(P〈0.05);临床Ⅲ、Ⅳ期MESO表达水平(1.5100±0.4142,3.6087±3.3959)高于I、Ⅱ期(1.1190±0.4909,1.7895±2.6320),差异有统计学意义(P〈0.05)。MESO表达水平与病理分级有关(P〈0.05),而与患者年龄和血清CA125水平无关(P〉0.05)。结论MESOmRNA及蛋白在卵巢癌和交界性肿瘤组表达增高,MESO可能参与卵巢癌的黏附转移。 Objective To investigate the expression of mesothelin (MESO) mRNA and protein and its significance in ovarian carcinomas. Methods Semi-quantitative reverse transcription polymerase chain reaction (RT-PCR) and immunohistochemistry were used to detect the expression level of MESO mRNA and protein, respectively, in 124 samples of ovarian tumor and normal tissues, including 84 epithelial ovarian carcinomas, 1 2 borderline ovarian tumors , 1 6 benign ovarian tumors and 1 2 normal ovarian tissues. Results The expression of MESO mRNA and protein in epithelial ovarian carcinomas ( 1. 4005 ± 0. 4646,2. 7857 ± 2. 2712) and borderline ovarian tumors ( 1. 0650±0.3100, 2. 9167±2.391 ) were significantly higher than that in benign ovarian tumors (0.6463±0. 2419, 1. 2500 ± 1. 6125 ) and normal ovarian tissues (0.6439 ± 0.2729, 0. 9167 ± 1. 2401 ) ( P 〈 0. 05 ), and also significantly higher in serous cystadenocarcinoma ( 1. 5255 ± 0.4151,3. 3036 ± 2.6141 ) and endometrioid carcinoma ( 1. 5250 ± 0.5419, 3. 0000 ± 2. 3094 ) than that in mueinous eystadenoeareinoma ( 1. 0675 ± 0.3149,1. 0556 ± 1. 9242 ) ( P 〈 0.05 ). The expression of MESO mRNA and protein in stages Ⅲ and Ⅳ carcinomas (1. 5100±0.4142,3. 6087 ± 3. 3959) was significantly higher than that in stages I and II carcinomas ( 1.1190 ± 0.4909,1. 7895 ± 2.6320 ;P 〈 0.05) , and also significantly higher in grade 3 carcinomas than that in grade 1 and 2 ones (P 〈0.05 ) , but was not correlate with age or serum CA125 of the patients (P 〉 0.05 ). Condusion The results of this study demonstrated that the expression of MESO mRNA and protein is increased in ovarian carcinomas and borderline ovarian tumors, and MESO may play a role in the adhesion and dissemination of ovarian carcinomas.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2008年第4期288-291,共4页 Chinese Journal of Oncology
关键词 间皮素 卵巢肿瘤 黏附 逆转录聚合酶链反应 免疫组织化学 Mesothelin Ovarian neoplasms Adhesion RT-PCR Immunohistochemistry
  • 相关文献

参考文献5

  • 1康玉,徐丛剑,刘惜时,邵志敏,欧周罗,罗建明,吴超群,钟翠平,顾健人.自杀性肿瘤疫苗对大鼠卵巢癌的治疗作用及其安全性研究[J].中华肿瘤杂志,2006,28(9):654-657. 被引量:5
  • 2Bera TK, Pastan I. Mesothelin is not required for normal mouse development or reproduction. Mol Cell Biol, 2000, 20:2902-2906. 被引量:1
  • 3Hassan R, Remalev AT, Sampson ML, et al. Detection and quantitation of serum mesothelin, a tumor marker for patients with mesothelioma and ovarian cancer. Clin Cancer Res, 2006, 12:447-453. 被引量:1
  • 4Rosen DG, Wang L, Atldnson JN, et al. Potential markers that complement expression of CA125 in epithelial ovarian cancer. Gynecol Oncol, 2005, 99:267-277. 被引量:1
  • 5Chang K, Pastan I. Molecular cloning of mesothdin, a differentiation antigen present an mesothelium, mesotheliomas, and ovarian cancers. Cell Biology, 1996, 93:136-140. 被引量:1

二级参考文献2

共引文献4

同被引文献23

  • 1陈健华,倪润洲,肖明兵,陆翠华,华国平,毛振彪.血清CA125检测在腹水性质分析中的诊断价值[J].江苏医药,2007,33(5):441-442. 被引量:12
  • 2陈书成,刘雅坤,吴小华,单保恩,陈兴,孙东霞,王莉.抗人可溶性间皮素相关蛋白单克隆抗体的制备及特性鉴定[J].细胞与分子免疫学杂志,2007,23(3):246-248. 被引量:5
  • 3Bouchard D,Morisset D,Bourbonnais Y,et al.Proteins with whey-acidic-protein motifs and cancer[J].Lancet Oncol,2006,7:167-174. 被引量:1
  • 4Montagnana M,Lippi G,Ruzzenente O,et al.The utility of serum human epididymis protein 4 (HE4) in patients with a pelvic mass[J].J Clin Lab Anal,2009,23:331-335. 被引量:1
  • 5Drapkin R,Von Horsten H H,Lin Y F,et al.Human epididymis protein 4 (HE4)is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas[J].Cancer Res,2005,65:2162-2169. 被引量:1
  • 6Galgano M T,Hampton G M,Frierson H F,et a1.Comprehensive analysis of HE4 expression in normal and malign ant human tissues[J].Mod Pathol,2006,19:847-853. 被引量:1
  • 7Moore R G,Brown A K,Miller M C,et al.The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with pelvic mass[J].Gynecol Oncol,2008,108:402-408. 被引量:1
  • 8Kirchhoff C,Habben I,Ivell R,et al.A major human epididymis-specific cDNA encodes a protein with sequence homology to extracellular proteinase inhibitors[J].Biol Reprod,1991,45:350-357. 被引量:1
  • 9Schummer M,Ng W V,Bumgarner R E,et al.Comparative hybridization of an array of 21,500 ovarian cDNAs for the discovery of genes overexpressed in ovarian carcinomas[J].Gene,l999,238:375-385. 被引量:1
  • 10Hellstrom I,Rayeraft J,Hayden-Ledbetter M,et al.The HE4 (WFDC2)protein is a biomarker for ovarian carcinoma[J].Cancer Res,2003,63:3695-3700. 被引量:1

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部